Company / Working Capital
Co-Diagnostics, Inc. Working Capital History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$10.2M
FY2025
5-year range
$10.2M / $102.5M
FY2021-FY2025
Trend
-59.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital has declined for 4 consecutive years, from $103M in FY2021 to $10M in FY2025.
Based on SEC 10-K filings.
$10M in FY2025 with a 5-year CAGR of -30.8%.
Declined from $56M to $10M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -51.5%
- 5-Year CAGR
- -30.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- Co-Diagnostics, Inc.'s working capital has declined for 4 consecutive years.
- 5-year CAGR of -30.8%, indicating a declining trend.
- In FY2025, working capital decreased 59.3% year-over-year.
- Peak working capital was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.2M | -59.3% |
| FY2024 | $25.0M | -55.7% |
| FY2023 | $56.4M | -36.5% |
| FY2022 | $88.9M | -13.3% |
| FY2021 | $102.5M | +60.6% |
| FY2020 | $63.8M | +4982.8% |
| FY2019 | $1.3M | +196.6% |
| FY2018 | -$1.3M | -134.0% |
| FY2017 | $3.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026